FCPM III SERVICES B.V. Q2 2025 Filing
Filed August 14, 2025
Portfolio Value
$369.2B
Holdings
8
Report Date
Q2 2025
Filing Type
13F-HR
All Holdings (8 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | NAMSNEWAMSTERDAM PHARMA COMPANY | 10,632,113 | $192.5B | 52.16% | |
| 2 | DYNDYNE THERAPEUTICS INC | 5,462,846 | $52.0B | 14.09% | |
| 3 | REPLREPLIMUNE GROUP INC | 3,909,696 | $36.3B | 9.84% | |
| 4 | ENGNENGENE HOLDINGS INC | 9,632,561 | $35.1B | 9.50% | |
| 5 | BCYCBICYCLE THERAPEUTICS PLC | 3,452,330 | $24.0B | 6.50% | |
| 6 | CATBUSDASTRIA THERAPEUTICS INC | 4,107,537 | $23.4B | 6.34% | |
| 7 | RAPTRAPT THERAPEUTICS INC | 440,176 | $3.5B | 0.93% | |
| 8 | ENGNWENGENE HOLDINGS INC | 2,878,148 | $2.4B | 0.64% |